{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:42:12Z","timestamp":1790685732609,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jad.2022.12.050","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T20:16:46Z","timestamp":1671221806000},"page":"748-754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Psychotherapists' openness to engage their patients in Psilocybin-Assisted Therapy for mental health treatment"],"prefix":"10.1016","volume":"323","author":[{"given":"Priel","family":"Meir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jair C.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jad.2022.12.050_bb0005","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/NMD.0000000000000828","article-title":"A survey of American psychiatrists\u2019 attitudes toward classic hallucinogens","volume":"206","author":"Barnett","year":"2018","journal-title":"J. Nerv. Ment. Dis."},{"issue":"1","key":"10.1016\/j.jad.2022.12.050_bb0010","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1089\/jpm.2019.0603","article-title":"Defining the roles and research priorities for psychedelic-assisted therapies in patients with serious illness: expert clinicians' and investigators' perspectives","volume":"23","author":"Beaussant","year":"2020","journal-title":"J. Palliat. Med."},{"key":"10.1016\/j.jad.2022.12.050_bb0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuropharm.2018.02.018","article-title":"Psychedelics: where we are now, why we got here, what we must do","volume":"142","author":"Belouin","year":"2018","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.jad.2022.12.050_bb0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.jad.2022.12.050_bb0025","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-017-4777-4","article-title":"Regulation of human research with LSD in the United States (1949\u20131987)","volume":"235","author":"Bonson","year":"2018","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.jad.2022.12.050_bb0030","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/0269881118754710","article-title":"Psychedelics and the essential importance of context","volume":"32","author":"Carhart-Harris","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2022.12.050_bb0035","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archpsyc.1960.03590090042008","article-title":"Lysergic acid diethylamide (LSD-25) as a facilitating agent in psychotherapy","volume":"2","author":"Chandler","year":"1960","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2022.12.050_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116715","article-title":"A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses","volume":"411","author":"Chi","year":"2020","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.jad.2022.12.050_bb0045","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1176\/ajp.125.3.393","article-title":"The cyclic psychedelics","volume":"125","author":"Cohen","year":"1968","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jad.2022.12.050_bb0050","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s11845-021-02668-2","article-title":"Psychedelic perceptions: mental health service user attitudes to psilocybin therapy","volume":"191","author":"Corrigan","year":"2022","journal-title":"Ir. J. Med. Sci."},{"key":"10.1016\/j.jad.2022.12.050_bb0055","article-title":"Attitudes and beliefs about the therapeutic use of psychedelic drugs among psychologists in the United States","author":"Davis","year":"2021","journal-title":"J. Psychoactive Drugs"},{"issue":"5","key":"10.1016\/j.jad.2022.12.050_bb0060","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2022.12.050_bb0065","doi-asserted-by":"crossref","first-page":"528e539","DOI":"10.1097\/00005053-195812000-00006","article-title":"Psychotherapy with lysergic acid diethylamide","volume":"127","author":"Eisner","year":"1958","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.jad.2022.12.050_bb0070","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/0957154X17692197","article-title":"Concerns regarding conclusions made about LSD-treatments","volume":"28","author":"Erritzoe","year":"2017","journal-title":"Hist.Psychiatry"},{"key":"10.1016\/j.jad.2022.12.050_bb0075","doi-asserted-by":"crossref","first-page":"487e488","DOI":"10.1080\/08039488.2017.1336252","article-title":"Lessons to be learned from early psychedelic therapy in Denmark","volume":"71","author":"Erritzoe","year":"2017","journal-title":"Nordic J.Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2022.12.050_bb0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/1874473708666150107121331","article-title":"Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction","volume":"7","author":"Garcia-Romeu","year":"2014","journal-title":"Curr.Drug Abuse Rev."},{"issue":"4","key":"10.1016\/j.jad.2022.12.050_bb0085","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/09540261.2018.1486289","article-title":"Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions","volume":"30","author":"Garcia-Romeu","year":"2018","journal-title":"Int.Rev.Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2022.12.050_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216556","article-title":"Health professional beliefs, knowledge, and concerns surrounding medical cannabis \u2013 a systematic review","volume":"14","author":"Gardiner","year":"2019","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.jad.2022.12.050_bb0095","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","article-title":"Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases","volume":"202","author":"Gasser","year":"2014","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.jad.2022.12.050_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.112749","article-title":"The experimental effects of psilocybin on symptoms of anxiety and depression: a meta-analysis","volume":"284","author":"Goldberg","year":"2020","journal-title":"Psychiatry Res."},{"issue":"6","key":"10.1016\/j.jad.2022.12.050_bb0105","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/17512433.2020.1772054","article-title":"Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments","volume":"13","author":"Greenway","year":"2020","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.jad.2022.12.050_bb0110","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/0269881108094300","article-title":"Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later","volume":"22","author":"Griffiths","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2022.12.050_bb0115","series-title":"Psychedelic Drugs Reconsidered","author":"Grinspoon","year":"1979"},{"key":"10.1016\/j.jad.2022.12.050_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108652","article-title":"Knowledge, attitudes, and prescribing patterns of cannabis and cannabinoid-containing medicines among European healthcare workers: a systematic literature review","volume":"221","author":"Hordowicz","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jad.2022.12.050_bb0125","first-page":"109","article-title":"Nigerian medical students' opinions about individuals who use and abuse psychoactive substances","volume":"7","author":"James","year":"2013","journal-title":"Subst. Abus."},{"key":"10.1016\/j.jad.2022.12.050_bb0130","doi-asserted-by":"crossref","first-page":"315e320","DOI":"10.15288\/qjsa.1962.23.315","article-title":"A treatment program for alcoholics in a mental hospital","volume":"23","author":"Jensen","year":"1962","journal-title":"Q.J.Stud.Alcohol"},{"key":"10.1016\/j.jad.2022.12.050_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022101","article-title":"Knowledge and attitudes of Australian general practitioners towards medicinal cannabis: a cross-sectional survey","volume":"8","author":"Karanges","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.jad.2022.12.050_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.clinpsy.3.022806.091432","article-title":"Mediators and mechanisms of change in psychotherapy research","volume":"3","author":"Kazdin","year":"2007","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.jad.2022.12.050_bb0145","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jad.2021.09.041","article-title":"Dose effect of Psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis","volume":"296","author":"Li","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.12.050_bb0150","doi-asserted-by":"crossref","first-page":"34","DOI":"10.15288\/qjsa.1961.22.034","article-title":"The use of LSD-25 in the treatment of alcoholism and other psychiatric problems","volume":"22","author":"Maclean","year":"1961","journal-title":"Q.J.Stud.Alcohol"},{"issue":"1","key":"10.1016\/j.jad.2022.12.050_bb0155","doi-asserted-by":"crossref","DOI":"10.1111\/ijn.12836","article-title":"The effect of attitudes, subjective norms and stigma on health-care providers' intention to recommend medicinal cannabis to patients","volume":"27","author":"Melnikov","year":"2021","journal-title":"Int. J. Nurs. Pract."},{"key":"10.1016\/j.jad.2022.12.050_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114727","article-title":"Magic mushrooms \u2013 an exploratory look at how mental health professionals feel and think about Psilocybin","volume":"316","author":"Meyer","year":"2022","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2022.12.050_bb0165","series-title":"Serotonin in Psychiatric Disorders","first-page":"959","article-title":"Classic psychedelics as therapeutics for psychiatric disorders","volume":"49","author":"Nichols","year":"2020"},{"issue":"8","key":"10.1016\/j.jad.2022.12.050_bb2000","doi-asserted-by":"crossref","DOI":"10.1038\/nrn3530","article-title":"Effects of Schedule I drug laws on neuroscience research and treatment innovation","volume":"14","author":"Nutt","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"issue":"9","key":"10.1016\/j.jad.2022.12.050_bb0170","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038687","article-title":"So near yet so far: why won't the UK prescribe medical cannabis?","volume":"10","author":"Nutt","year":"2020","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.jad.2022.12.050_bb0175","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1177\/0022167817711304","article-title":"Developing guidelines and competencies for the training of psychedelic therapists","volume":"57","author":"Phelps","year":"2017","journal-title":"J. Humanist. Psychol."},{"key":"10.1016\/j.jad.2022.12.050_bb0180","series-title":"A step closer to legalizing magic mushrooms as FDA lets second research group use the \u2018breakthrough\u2019 drug in clinical trial to treat patients with depression","author":"Rahhal","year":"2019"},{"key":"10.1016\/j.jad.2022.12.050_bb0185","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fphar.2017.00974","article-title":"Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression","volume":"8","author":"Roseman","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.jad.2022.12.050_bb0190","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2022.12.050_bb0195","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuropharm.2017.12.040","article-title":"Psychiatry & the psychedelic drugs. Past, present, & future","volume":"142","author":"Rucker","year":"2018","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.jad.2022.12.050_bb1000","doi-asserted-by":"crossref","DOI":"10.1001\/archpsyc.1973.01750360040005","article-title":"Residential psychedelic (LSD) therapy for the narcoticaddict: a controlled study","volume":"28","author":"Savage","year":"1973","journal-title":"Arch. Gen. Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2022.12.050_bb0200","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3390\/biomedicines8090331","article-title":"Psilocybin as a new approach to treat depression and anxiety in the context of life-threatening diseases - a systematic review and meta-analysis of clinical trials","volume":"8","author":"Vargas","year":"2020","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.jad.2022.12.050_bb3000","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/09540261.2018.1474088","article-title":"Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy","volume":"30","author":"Walsh","year":"2018","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.jad.2022.12.050_bb0205","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s42238-021-00100-1","article-title":"A systematic review of medical students' and professionals' attitudes and knowledge regarding medical cannabis","volume":"3","author":"Weisman","year":"2021","journal-title":"J.Cannabis Res."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722014100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722014100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T03:58:43Z","timestamp":1759031923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032722014100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":44,"alternative-id":["S0165032722014100"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2022.12.050","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychotherapists' openness to engage their patients in Psilocybin-Assisted Therapy for mental health treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2022.12.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}